Methods for identifying inhibitors of cytochrome P450RAI
Abstract
A method of identifying a compound which is an inhibitor of the enzyme cytochrome P450RAI is performed by selecting a compound that has retinoid activity in an art recognized assay and includes a benzoic acid, benzoic acid ester, naphthoic acid ester or heteroaryl carboxylic acid or ester moiety, with a partial structure of —A(R 2 )—(CH 2 ) n—COOR 8 where n is 0 and the remaining variables are as described in the specification and claims. Thereafter, a compound having the cytochrome P450RAI inhibitory activity is identified and selected where the compound has the —A(R 2 )—(CH 2 ) 2 —COOR 8 partial structure wherein the variable n is 1 or 2.
Claims
exact text as granted — not AI-modified1. A method identifying a compound which is an inhibitor of the enzyme P450RAI, the method comprising:
selecting a compound that has activity as a retinoid in an art recognized assay which demonstrates retinoid-like activity; the retinoid compound including a moiety selected from the group consisting of benzoic acid, benzoic acid ester, naphthoic acid, naphthoic acid ester, heteroaryl carboxylic acid and heteroaryl carboxylic acid ester, with a partial structure of —A(R 2 )—(Ch 2 ) n —COOR 8 where n is 0, A is a phenyl or naphthyl group, or heteroaryl selected from a group consisting of pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, oxazolyl, imidazolyl and pyrrazoly, said phenyl, naphthyl and heteroaryl groups being optionally substituted with one or two R 2 groups; R 2 is independently H, alkyl of 1 of 6 carbons, F, Cl, Br, I, CF 3 , fluoro substituted alkyl of 1 of 6 carbons, —CH 2 O(C 1-6 -alkyl), or a cation of a pharmaceutically acceptable base, and
further selecting a compound that is a homolog of the selected retinoid compound where in the formula of the homolog n is 1 or 2 which compound is identified as an inhibitor of cytochrome P450RAI.
2. A method in accordance with claim 1 wherein a homolog is selected where in the formula of the homolog n is 1.
3. A method in accordance with claim 1 further comprising the step of synthesizing the selected homolog.
4. A method in accordance with claim 3 wherein a homolog is synthesized where in the formula of the homolog n is 1.
5. A method in accordance with claim 3 wherein the step of synthesizing the homolog utilizes a homologation procedure wherein a chain of a carboxylic acid or of carboxylic ester of the partial formula —A(R 2 )—(CH 2 ) n —COOR 8 is lengthened by adding one or two (CH 2 ) units.
6. A method in accordance with claim 5 wherein the step of synthesizing the homolog utilizes Arndt-Eistert method of synthesis.
7. A method in accordance with claim 4 where the step of synthesizing the homolog includes a reaction with a reagent selected from the group consisting of the formula set forth belowJoin the waitlist — get patent alerts
Track US6855512B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.